News GSK planning 1,200 job cuts in Belgium, says paper GSK is said to be preparing to cut around 1,200 positions from its workforce in Belgium as part of a cost-saving programme launched by CEO Luke Miels.
News BioNTech winds down COVID jab manufacturing, shedding staff BioNTech's plan to shed 22% of its workforce and stop COVID-19 vaccine production has earned it a rebuke from Germany's third-largest labour union.
News Evotec slashes staff as turnaround plan gathers pace Evotec has announced the next phase of its company overhaul, dubbed Horizon, that will see 800 people lose their jobs in a bid to cut €75m in costs.
News Bayer beats expectations with tougher times looming Bayer's third-quarter sales came in a bit higher than anticipated, but the company is girding its loins for a challenging period ahead.
News NHS braces for thousands of redundancies UK Health Secretary Wes Streeting has given the green light to a series of NHS reforms that will see around 18,000 administrative roles abolished.
News Chaos as layoffs start to hit HHS agencies Job losses start at federal agencies, including HHS, but initial reports suggest some workers who have been let go are quickly being reinstated.
News GSK gets second cancer drug approval from Nuvalent buy The FDA has cleared GSK's ALK inhibitor Nelkarmi for a form of lung cancer, the second product from its $10.6bn acquisition of Nuvalent.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.